Found: 7
Select item for more details and to access through your institution.
Demonstrating Value for Biosimilars: A Conceptual Framework... [including commentary by Michael Kleinrock].
- Published in:
- American Health & Drug Benefits, 2015, v. 8, n. 3, p. 129
- By:
- Publication type:
- Article
625 - Efficacy and safety of 1.5% ruxolitinib cream in patients with facial and/or neck atopic dermatitis: a randomized, double-blind, decentralized phase 2 study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.009
- By:
- Publication type:
- Article
An Intrinsic ATPase Activity of Phospho-MEK-1 Uncoupled from Downstream ERK Phosphorylation.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A640
- By:
- Publication type:
- Article
A Second p53 Binding Site in the Central Domain of Mdm2 Is Essential for p53 Ubiquitination.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A273, doi. 10.1096/fasebj.21.5.a273-b
- By:
- Publication type:
- Article
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis.
- Published in:
- Rheumatology & Therapy, 2020, v. 7, n. 4, p. 793, doi. 10.1007/s40744-020-00227-2
- By:
- Publication type:
- Article
Postapproval Development Options in COPD: A Case Study in Value-Based Healthcare Systems.
- Published in:
- American Health & Drug Benefits, 2011, v. 4, n. 1, p. 19
- By:
- Publication type:
- Article
Modulation of kinase-inhibitor interactions by auxiliary protein binding: Crystallography studies on Aurora A interactions with VX-680 and with TPX2.
- Published in:
- Protein Science: A Publication of the Protein Society, 2008, v. 17, n. 10, p. 1791, doi. 10.1110/ps.036590.108
- By:
- Publication type:
- Article